Clinical and pathological characteristics of screen-detected versus clinically diagnosed prostate cancer in Nanjing, China

Medical Oncology

Volumn 28, Issue 1, 2011, Pages 357-364

  Hua, Lixin ^a   Qiao, Di ^b   Xu, Bin ^a   Feng, Ninghan ^a   Cheng, Gong ^a   Zhang, Jiexiu ^a   Song, Ninghong ^a   Zhang, Wei ^a   Yang, Jie ^a   Chen, Jiangang ^a   Sui, Yuangeng ^a   Wu, Hongfei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

China; Prostate cancer; Prostate specific antigen; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER SCREENING; CHINA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR DIFFERENTIATION;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CHINA; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 79952249512     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9409-3     Document Type: Article

References (37)

1. MK Brawer MP Chetner J Beatie DM Buchner RL Vessella PH Lange 1992 Screening for prostatic carcinoma with prostate specific antigen J Urol 147 841 845 1371559 1:STN:280:DyaK387mslChuw%3D%3D
2. WJ Catalona DS Smith TL Ratliff KM Dodds DE Coplen JJ Yuan JA Petros GL Andriole 1991 Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1156 1161 1707140 10.1056/ NEJM199104253241702 1:STN:280:DyaK3M7oslSksA%3D%3D
3. F Labrie A Dupont R Suburu L Cusan M Tremblay JL Gomez J Emond 1992 Serum prostate specific antigen as pre-screening test for prostate cancer J Urol 147 846 851 1371560 1:STN:280:DyaK387mslCgsg%3D%3D (discussion 51-52)
4. K Imai S Zinbo K Shimizu H Yamanaka F Kumasaka Z Sato 1988 Clinical characteristics of prostatic cancer detected by mass screening Prostate 12 199 207 3375142 10.1002/pros.2990120303 1:STN:280:DyaL1c3jsVWrsQ%3D%3D
5. T Makinen TL Tammela M Hakama UH Stenman S Rannikko J Aro H Juusela L Maattanen A Auvinen 2003 Tumor characteristics in a population-based prostate cancer screening trial with prostate-specific antigen Clin Cancer Res 9 2435 2439 12855615 (Pubitemid 36842082)
6. IW van der Cruijsen-Koeter AN Vis MJ Roobol MF Wildhagen HJ de Koning TH van der Kwast FH Schroder 2005 Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam J Urol 174 121 125 15947595 10.1097/01.ju.0000162061.40533.0f (Pubitemid 40825690)
7. EL Paquette L Sun LR Paquette R Connelly DG McLeod JW Moul 2002 Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing Urology 60 756 759 12429290 10.1016/S0090-4295(02)01960-X (Pubitemid 35300331)
8. KA Roehl SE Eggener S Loeb ND Smith JA Antenor WJ Catalona 2006 Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results Urol Oncol 24 465 471 17138126 (Pubitemid 44810008)
9. SB Zeliadt R Etzioni SD Ramsey DF Penson AL Potosky 2007 Trends in treatment costs for localized prostate cancer: the healthy screenee effect Med Care 45 154 159 17224778 10.1097/01.mlr.0000241044.09778.3f
10. AW Hsing L Tsao SS Devesa 2000 International trends and patterns of prostate cancer incidence and mortality Int J Cancer 85 60 67 10585584 10.1002/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B 1:STN:280:DC%2BD3c%2FlsVektQ%3D%3D
11. M Quinn P Babb 2002 Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons BJU Int 90 162 173 12081758 10.1046/j.1464-410X.2002.2822.x 1:STN:280: DC%2BD38zjvFChtQ%3D%3D (Pubitemid 34779587)
12. HG Sim CW Cheng 2005 Changing demography of prostate cancer in Asia Eur J Cancer 41 834 845 15808953 10.1016/j.ejca.2004.12.033 (Pubitemid 40467547)
13. F Gu 2003 Changing constituents of genitourinary cancer in recent 50 years in Beijing Chin Med J (Engl) 116 1391 1393 (Pubitemid 37184847)
14. HW Gao YL Li S Wu YS Wang HF Zhang YZ Pan L Zhang H Tateno I Sato M Kuwahara XJ Zhao 2005 Mass screening of prostate cancer in a Chinese population: the relationship between pathological features of prostate cancer and serum prostate specific antigen Asian J Androl 7 159 163 15897972 10.1111/j.1745-7262. 2005.00029.x (Pubitemid 41051421)
15. M Kuwahara T Tochigi S Kawamura Y Ogata N Xu H Wang H Zhang S Li X Li X Zhao 2003 Mass screening for prostate cancer: a comparative study in Natori, Japan and Changchun, China Urology 61 137 141 12559284 10.1016/S0090-4295(02) 02093-9 (Pubitemid 36151729)
16. X Li I Tsuji M Kuwahara H Zhang H Wang L Zhang G Ji X Zhao 2004 Mass screening of prostate cancer in Changchun City of China Int Urol Nephrol 36 541 548 15787333 10.1007/s11255-004-0842-0 (Pubitemid 40208033)
17. HF Zhang HL Wang N Xu SW Li GY Ji XM Li YZ Pan L Zhang XJ Zhao HW Gao 2004 Mass screening of 12,027 elderly men for prostate carcinoma by measuring serum prostate specific antigen Chin Med J (Engl) 117 67 70 (Pubitemid 38240233)
18. AY Chuang SJ Chang CF Horng MH Tsou 2007 Study of prostate cancer pathologic features in Chinese populations Urology 69 915 920 17482934 10.1016/j.urology.2007.01.051 (Pubitemid 46670233)
19. M Peyromaure B Debre K Mao G Zhang Y Wang Z Sun D Xu J Jiang Y Sun 2005 Management of prostate cancer in China: a multicenter report of 6 institutions J Urol 174 1794 1797 16217289 10.1097/01.ju.0000176817.46279.93 (Pubitemid 41546942)
20. K Uchida H Takeshima H Akaza Y Ono 2000 Screening for prostate cancer using prostate-specific antigen alone as a first-line checkup parameter: results of the health checkup system Jpn J Clin Oncol 30 95 100 10768873 10.1093/jjco/hyd021 1:STN:280:DC%2BD3c3ivFelsg%3D%3D
21. M Ohori TM Wheeler PT Scardino 1994 The New American Joint Committee on Cancer and International Union against Cancer TNM classification of prostate cancer. Clinicopathologic correlations Cancer 74 104 114 7516262 10.1002/1097-0142(19940701)74:1<104::AID-CNCR2820740119>3.0.CO;2-5 1:STN:280:DyaK2c3ntlSksQ%3D%3D (Pubitemid 24187618)
22. DF Gleason 1988 Histologic grade, clinical stage, and patient age in prostate cancer NCI Monogr 7 15 18 3173500
23. EP DeAntoni ED Crawford JE Oesterling CA Ross ER Berger DG McLeod F Staggers NN Stone 1996 Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study Urology 48 234 239 8753735 10.1016/S0090-4295(96)00091-X 1:STN:280:DyaK28zlt1OitA%3D%3D (Pubitemid 26279616)
24. SY Hosseini M Moharramzadeh AR Ghadian H Hooshyar AR Lashay MR Safarinejad 2007 Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran Int J Urol 14 406 411 17511722 10.1111/j.1442-2042.2006.01729.x (Pubitemid 46776209)
25. JH Ku JO Ahn CH Lee NK Lee YH Park SS Byun C Kwak SE Lee 2002 Distribution of serum prostate-specific antigen in healthy Korean men: influence of ethnicity Urology 60 475 479 12350489 10.1016/S0090-4295(02)01807-1 (Pubitemid 35292177)
26. TO Morgan SJ Jacobsen WF McCarthy DJ Jacobson DG McLeod JW Moul 1996 Age-specific reference ranges for prostate-specific antigen in black men N Engl J Med 335 304 310 8663870 10.1056/NEJM199608013350502 1:STN:280: DyaK283otlWntA%3D%3D (Pubitemid 26362377)
27. JE Oesterling Y Kumamoto T Tsukamoto CJ Girman HA Guess N Masumori SJ Jacobsen MM Lieber 1995 Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men Br J Urol 75 347 353 7537604 10.1111/j.1464-410X.1995.tb07347.x 1:STN:280:DyaK2M3ltlOktA%3D%3D
28. K Mistry G Cable 2003 Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma J Am Board Fam Pract 16 95 101 12665174 10.3122/jabfm.16.2.95
29. GL Andriole DL Levin ED Crawford EP Gelmann PF Pinsky D Chia BS Kramer D Reding TR Church RL Grubb G Izmirlian LR Ragard JD Clapp PC Prorok JK Gohagan 2005 Prostate cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screening round of a randomized trial J Natl Cancer Inst 97 433 438 15770007 10.1093/jnci/dji065 (Pubitemid 40528606)
30. CH Bunker AL Patrick BR Konety R Dhir AM Brufsky CA Vivas MJ Becich DL Trump LH Kuller 2002 High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey Cancer Epidemiol Biomarkers Prev 11 726 729 12163325 (Pubitemid 34851906)
31. W Horninger A Reissigl H Rogatsch H Volgger M Studen H Klocker G Bartsch 2000 Prostate cancer screening in the Tyrol, Austria: experience and results Eur J Cancer 36 1322 1335 10882875 10.1016/S0959-8049(00)00113-1 1:STN:280:DC%2BD3czktVOruw%3D%3D
32. L Maattanen M Hakama TL Tammela M Ruutu M Ala-Opas H Juusela P Martikainen UH Stenman A Auvinen 2007 Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial Br J Cancer 96 56 60 17213825 10.1038/sj.bjc.6603522 1:STN:280:DC%2BD2s%2Fhs1Onsw%3D%3D (Pubitemid 46094639)
33. A Farkas D Schneider M Perrotti KB Cummings WS Ward 1998 National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening Urology 52 444 448 9730458 10.1016/S0090-4295(98)00242-8 1:STN:280:DyaK1czpvVahtA%3D%3D (discussion 8-9) (Pubitemid 28399912)
34. K Okihara H Nakanishi T Nakamura Y Mizutani A Kawauchi T Miki 2005 Clinical characteristics of prostate cancer in Japanese men in the eras before and after serum prostate-specific antigen testing Int J Urol 12 662 667 16045559 10.1111/j.1442-2042.2005.01113.x (Pubitemid 41725492)
35. AS Robbins D Yin A Parikh-Patel 2007 Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004 Am J Epidemiol 166 71 78 17426038 10.1093/aje/kwm052 (Pubitemid 47234297)
36. CD Scales Jr LH Curtis RD Norris KA Schulman DM Albala JW Moul 2006 Prostate specific antigen testing in men older than 75 years in the United States J Urol 176 511 514 16813879 10.1016/j.juro.2006.03.060 (Pubitemid 43949407)
37. PF Pinsky GL Andriole BS Kramer RB Hayes PC Prorok JK Gohagan 2005 Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial J Urol 173 746 750 15711261 10.1097/01.ju.0000152697.25708.71 discussion 50-1 (Pubitemid 40239332)